Evidence map›Paper›PMID 41086147›Full record

Observational studyPloS one2025

Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain.

Iván Chivite, Vanessa Guilera, Pilar Callau, Raquel Aguiló, Elisa de Lazzari, M J Merino, Laia Diaz, Alba Carrodeguas, José Luis González-Sánchez, Josep Mallolas

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Iván ChiviteHospital Clínic de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-1959-246X
Vanessa GuileraHospital Clínic de Barcelona, Barcelona, Spain.
Pilar CallauHospital Clínic de Barcelona, Barcelona, Spain.
Raquel AguilóHospital Clínic de Barcelona, Barcelona, Spain.
Elisa de LazzariHospital Clínic de Barcelona, Barcelona, Spain.
M J MerinoHospital Clínic de Barcelona, Barcelona, Spain.
Laia DiazHospital Clínic de Barcelona, Barcelona, Spain.
Alba CarrodeguasGilead Sciences, Spain.
José Luis González-SánchezGilead Sciences, Spain.
Josep MallolasHospital Clínic de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHuman immunodeficiency virus (HIV) and hepatitis C virus (HCV) continue to be a significant public health concern. Screening is a critical strategy for HIV and HCV control to reach the World Health Organization's elimination goals by 2030. This study assessed the outcomes of a healthcare quality improvement project integrating routine opportunistic BBV screening and linkage to care in emergency services for high-risk patients. This project aimed at providing HIV and HCV fast-track screening among patients seeking care in the emergency department of Hospital Clínic de Barcelona (Spain) and re-engage individuals previously diagnosed but not currently in care.

methodsThis observational study included patients ≥18 years old who presented to the emergency department reporting genitourinary complaints or recent high-risk exposures for HIV, HCV, or other sexually transmitted infections. Using the FOCUS TEST model as a framework, a systematic opportunistic HIV and HCV screening and offered linkage to care (LTC) to patients with positive test results was conducted. Screening was performed using fourth-generation chemiluminescence immunoassays for HIV and HCV antibodies, including p24 antigen detection, with confirmatory HCV RNA testing by PCR. The FOCUS TEST model supports automatic integration of testing into routine workflows and staff training. For each of these blood-borne viruses, the screening volume, testing uptake, seroprevalence, characteristics of patients with new infections, and LTC rates were analyzed.

resultsBetween January 2020 and December 2022, 35,285 blood-borne virus tests were performed. The number of new infections detected was 38 for HIV (0.41% seroprevalence) and 34 for HCV (0.19% HCV RNA prevalence). LTC was achieved for 89% and 100% of patients diagnosed with new HIV and HCV infections, respectively. A separate set of patients with HIV (n = 297) or HCV (n = 25) infections identified prior to this screening program were re-linked to care via this project.

conclusionThis healthcare quality improvement project was feasible and successful in achieving its goal of providing systematic opportunistic HIV and HCV screening to patients seeking urgent care. Importantly, the program also enabled LTC of a considerable number of patients previously diagnosed but not retained in care, further strengthening its impact on public health. These outcomes align with global goals for the elimination of HIV and HCV as public health threats by 2030 and demonstrate that similar fast-track screening and linkage strategies could be effectively implemented in other urban emergency settings with appropriate infrastructure and support.

Indexed as

Hepatitis CHIV InfectionsMass ScreeningAdultEmergency Service, HospitalFemaleHepacivirusHumansMaleMiddle AgedSpain

Identifiers

PMID41086147
PMCPMC12520359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.